表观遗传学在扩张型心肌病中的研究进展

沈丽娟; 陆曙; 孔令晶; 杨葛魏; 邢清敏

doi:10.13201/j.issn.1001-1439.2021.02.002

表观遗传学在扩张型心肌病中的研究进展

- 1 南京中医药大学无锡附属医院(江苏无锡, 214071);
- 2 南京中医药大学
基金项目:
江苏省自然科学基金面上项目(No:BK20201141)

江苏省中医药管理局领军人才培养(No:SLJ0217)

无锡市2019年度“太湖人才计划”国际国内顶尖医学团队(No:锡组通【2019】68号)

无锡市“双百”中青年医疗卫生拔尖人才(No:BJ2020067)

详细信息

通讯作者: 陆曙,E-mail:21045659@qq.com

中图分类号: R542.2

收稿日期: 2020-07-19

Recent advances of epigenetics in dilated cardiomyopathy

- 1 Wuxi Affiliated Hospital of Nanjing University of Chinese Medicine, Wuxi, Jiangsu, 214071, China;
- 2 Nanjing University of Chinese Medicine

More Information

Corresponding author: LU Shu, E-mail: 21045659@qq.com

Received Date: 19 July 2020

摘要

摘要: 扩张型心肌病(dilated cardiomyopathy,DCM)是以扩大的心室和收缩功能障碍为特征的一种心肌病。DCM在所有心肌病中发病率最高,是一种严重威胁人类健康与生命的重大慢性病。DCM的病因及发病机制未完全明确,亦无特效药物及方法。因此,探寻DCM新的发病机制,从而寻找新的治疗方法和药物靶点,对临床救治具有重大意义。表观遗传学是不改变基因序列而引起的细胞表型和基因表达的可遗传改变,并受基因与环境相互作用的影响。本文将从DNA甲基化、组蛋白修饰、染色质重塑和非编码RNA等4个主要表观遗传学角度,综述DCM表观遗传学领域的一些新进展,为诊治DCM提供潜在的新途径。
- 扩张型心肌病 /
- 表观遗传学 /
- DNA甲基化 /
- 组蛋白 /
- 非编码RNA
Abstract: Dilated cardiomyopathy(DCM) has the highest morbidity among all the cardiomyopathies which was characterized by enlarged ventricle and loss of systolic function. DCM is a serious chronic disease which seriously threatens human health. The etiology and pathogenesis of DCM are not completely clear, and there is no specific treatment drugs and methods. Therefore, it is great important for clinical treatment to explore the new pathogenesis of DCM and find new treatment methods and drug targets. Epigenetics does not involve the changes of genetic sequences but focuses on the stable inheritance of genes in different individuals. It is affected by the interaction between genes and environments. We present some of the recent progress in the field of epigenetics in DCM by focusing on the three major epigenetic modifications, that is, DNA methylation, histone modification, chromatin remodeling, and noncoding RNAs which have the promise to yield potential new avenues for more effective treatment of the disease.
- dilated cardiomyopathy /
- epigenetics /
- chromatin /
- DNA methylation /
- histone modification

HTML全文

参考文献(47)

[1]	Weintraub RG,Semsarian C,Macdonald P.Dilated cardiomyopathy[J].Lancet,2017,390(10092):400-414.
[2]	庞军,吴强,程文立.泛素蛋白酶体系在扩张型心肌病发生发展中的作用研究进展[J].临床心血管病杂志,2020,36(10):882-885.
[3]	中华医学会心血管病学分会,中国心肌炎心肌病协作组.中国扩张型心肌病诊断和治疗指南[J].临床心血管病杂志,2018,34(5):421-434.
[4]	Cho KW,Lee J,Kim Y.Genetic variations leading to familial dilated cardiomyopathy[J].Mol Cells,2016,39(10):722-727.
[5]	Portela A,Esteller M.Epigenetic modifications and human disease[J].Nat Biotechnol,2010,28(10):1057-1068.
[6]	Rosa-Garrido M,Chapski DJ,Vondriska TM.Epigenomes in cardiovascular disease[J].Circ Res,2018,122(11):1586-1607.
[7]	Liu Y,Tian X,Liu S,et al.DNA hypermethylation:A novel mechanism of CREG gene suppression and atherosclerogenic endothelial dysfunction[J].Redox Biol,2020,32:101444.
[8]	Moore LD,Le T,Fan G.DNA methylation and its basic function[J].Neuropsychopharmacology,2013,38(1):23-38.
[9]	Chen Z,Zhang Y.Role of Mammalian DNA methyltransferases in development[J].Annu Rev Biochem,2020,89:135-158.
[10]	He Y,Ling S,Sun Y,et al.DNA methylation regulates α-smooth muscle actin expression during cardiac fibroblast differentiation[J].J Cell Physiol,2019,234(5):7174-7185.
[11]	Chaturvedi P,Kalani A,Givvimani S,et al.Differential regulation of DNA methylation versus histone acetylation in cardiomyocytes during HHcy in vitro and in vivo:an epigenetic mechanism[J].Physiol Genomics,2014,46(7):245-255.
[12]	Luo C,Hajkova P,Ecker JR.Dynamic DNA methylation:In the right place at the right time[J].Science,2018,361(6409):1336-1340.
[13]	Gilsbach R,Preissl S,Grüning BA,et al.Dynamic DNA methylation orchestrates cardiomyocyte development,maturation and disease[J].Nat Commun,2014,5:5288.
[14]	Movassagh M,Choy MK,Knowles DA,et al.Distinct epigenomic features in end-stage failing human hearts[J].Circulation,2011,124(22):2411-2422.
[15]	Haas J,Frese KS,Park YJ,et al.Alterations in cardiac DNA methylation in human dilated cardiomyopathy[J].EMBO Mol Med,2013,5(3):413-429.
[16]	Meder B,Haas J,Sedaghat-Hamedani F,et al.Epigenome-wide association study identifies cardiac gene patterning and a novel class of biomarkers for heart failure[J].Circulation,2017,136(16):1528-1544.
[17]	Jo BS,Koh IU,Bae JB,et al.Methylome analysis reveals alterations in DNA methylation in the regulatory regions of left ventricle development genes in human dilated cardiomyopathy[J].Genomics,2016,108(2):84-92.
[18]	Koczor CA,Lee EK,Torres RA,et al.Detection of differentially methylated gene promoters in failing and nonfailing human left ventricle myocardium using computation analysis[J].Physiol Genomics,2013,45(14):597-605.
[19]	沈丽娟,戴飞,陆曙,等.苓桂养心汤对扩张型心肌病大鼠心肌保护作用及肌浆网钙调控蛋白的影响[J].中国实验方剂学杂志,2017,23(18):145-151.
[20]	张阳,张志宇,王辉,等.表观遗传学在心力衰竭中的最新研究进展[J].中国医学科学院学报,2020,42(1):103-107.
[21]	Fang X,Poulsen RR,Wang-Hu J,et al.Knockdown of DNA methyltransferase 3a alters gene expression and inhibits function of embryonic cardiomyocytes[J].FASEB J,2016,30(9):3238-3255.
[22]	Han P,Li W,Yang J,et al.Epigenetic response to environmental stress:Assembly of BRG1-G9a/GLP-DNMT3 repressive chromatin complex on Myh6 promoter in pathologically stressed hearts[J].Biochim Biophys Acta,2016,1863(7 Pt B):1772-1781.
[23]	Draizen EJ,Shaytan AK,Marinormairenz L,et al.HistoneDB 2.0:a histone database with variants-an integrated resource to explore histones and their variants[J].Database(Oxord),2016,2016:1-2.
[24]	Venkatesh S,Workman JL.Histone exchange,chromatin structure and the regulation of transcription[J].Nat Rev Mol Cell Biol,2015,16(3):178-189.
[25]	Bannister AJ,Kouzarides T.Regulation of chromatin by histone modifications[J].Cell Res,2011,21(3):381-395.
[26]	Ito E,Miyagawa S,Fukushima S,et al.Histone modification is correlated with reverse left ventricular remodeling in nonischemic dilated cardiomyopathy[J].Ann Thorac Surg,2017,104(5):1531-1539.
[27]	Gallinari P,Di Marco S,Jones P,et al.HDACs,histone deacetylation and gene transcription:From molecular biology to cancer therapeutics[J].Cell Res,2007,17(3):195-211.
[28]	Ago T,Liu T,Zhai P,et al.A redox-dependent pathway for regulating class II HDACs and cardiac hypertrophy[J].Cell,2008,133(6):978-993.
[29]	Hohl M,Wagner M,Reil JC,et al.HDAC4 controls histone methylation in response to elevated cardiac load[J].J Clin Invest,2013,123(3):1359-1370.
[30]	Jeong MY,Lin YH,Wennersten SA,et al.Histone deacetylase activity governs diastolic dysfunction through a nongenomic mechanism[J].Sci Transl Med,2018,10(427):144.
[31]	Montgomery RL,Davis CA,Potthoff MJ,et al.Histone deacetylases 1 and 2 redundantly regulate cardiac morphogenesis,growth,and contractility[J].Genes Dev,2007,21(14):1790-1802.
[32]	Clapier CR,Cairns BR.The biology of chromatin remodeling complexes[J].Ann Rev Biochem,2009,78:273-304.
[33]	丁健,王飞,金景姬,等.表观遗传之染色质重塑[J].生物化学与生物物理进展,2015,42(11):994-1002.
[34]	Lickert H,Takeuchi JK,Von Both I,et al.Baf60c is essential for function of BAF chromatin remodelling complexes in heart development[J].Nature,2004,432(7013):107-112.
[35]	Sun X,Hota SK,Zhou YQ,et al.Cardiac-enriched BAF chromatin-remodeling complex subunit BAF60c regulates gene expression programs essential for heart development and function[J].Biol Open,2018,7(1):120.
[36]	Wang Z,Zhai W,Richardson JA,et al.Polybromo protein BAF180 functions in mammalian cardiac chamber maturation[J].Genes Dev,2004,18(24):3106-3116.
[37]	丁向阳,余再新.长链非编码RNA参与心肌缺血再灌注损伤的研究进展[J].临床心血管病杂志,2019,35(6):573-578.
[38]	Onrat ST,Onrat E,Ercan Onay E,et al.The genetic determination of the differentiation between ischemic dilated cardiomyopathy and idiopathic dilated cardiomyopathy[J].Genet Test Mol Biomarkers,2018,22(11):644-651.
[39]	Dziewiecka E,Totoń-Zurańska J,Wolkow P,et al.Relations between circulating and myocardialfibrosis-linked microRNAs with left ventricular reverseremodeling in dilated cardiomyopathy[J].Adv Clin Exp Med,2020,29(3):285-293.
[40]	Besler C,Urban D,Watzka S,et al.Endomyocardial miR-133a levels correlate with myocardial inflammation,improved left ventricular function,and clinical outcome in patients with inflammatory cardiomyopathy[J].Eur J Heart Fail,2016,18(12):1442-1451.
[41]	Satoh M,Minami Y,Takahashi Y,et al.Expression of microRNA-208 is associated with adverse clinical outcomes in human dilated cardiomyopathy[J].J Card Fail,2010,16(5):404-410.
[42]	Huang G,Liu J,Yang C,et al.RNA sequencing discloses the genome-wide profile of long noncoding RNAs in dilated cardiomyopathy[J].Mol Med Rep,2019,19(4):2569-2580.
[43]	谢青,杨锐,王利红,等.长链非编码RNA在原发性高血压中的研究现状[J].临床心血管病杂志,2018,34(12):1235-1239.
[44]	Chiang S,Huang M,Richardson DR.Treatment of dilated cardiomyopathy in a mouse model of Friedreich's ataxia using N-acetylcysteine and identification of alterations in microRNA expression that could be involved in its pathogenesis[J].Pharmacol Res,2020,159:104994.
[45]	Zhang X,Nie X,Yuan S,et al.Circulating long non-coding RNA ENST00000507296 is a prognostic indicator in patients with dilated cardiomyopathy[J].Mol Ther Nucleic Acids,2019,16:82-90.
[46]	Zhang Y,Zhang M,Xu W,et al.The long non-coding RNA H19 promotes cardiomyocyte apoptosis in dilated cardiomyopathy[J].Oncotarget,2017,8(17):28588-28594.
[47]	Huang S,Zhang L,Song J,et al.Long noncoding RNA MALAT1 mediates cardiac fibrosis in experimental postinfarct myocardium mice model[J].J Cell Physiol,2019,234(3):2997-3006.